FINWIRES · TerminalLIVE
FINWIRES

RBC Capital Downgrades Bio-Techne to Sector Perform From Outperform, Adjusts Price Target to $73 From $62

By

Bio-Techne (TECH) has an average rating of hold and mean price target of $70.33, according to analysts polled by FactSet.

What else is happening in Research?